American Journal of Obstetrics & Gynecology
Volume 191, Issue 4 , Pages 1063-1069 , October 2004

Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: A prospective investigation

  • Pathik D. Wadhwa, MD, PhD

      Affiliations

    • Departments of Psychiatry and Human Behavior
    • and Obstetrics and Gynecology
    • Corresponding Author InformationReprint requests: Pathik D. Wadhwa, MD, PhD, Behavioral Perinatology Research Program, 3117 Gillespie Neuroscience Research Facility, University of California, Irvine, Irvine, CA 92697-4260.
    • ,
  • Thomas J. Garite, MD

      Affiliations

    • and Obstetrics and Gynecology
    • ,
  • Manuel Porto, MD

      Affiliations

    • and Obstetrics and Gynecology
    • ,
  • Laura Glynn, PhD

      Affiliations

    • Departments of Psychiatry and Human Behavior
    • ,
  • Aleksandra Chicz-DeMet, PhD

      Affiliations

    • Departments of Psychiatry and Human Behavior
    • ,
  • Christine Dunkel-Schetter, PhD

      Affiliations

    • University of California, Irvine, Irvine, Calif, and Department of Psychology, University of California, Los Angeles, Calif
    • ,
  • Curt A. Sandman, PhD

      Affiliations

    • Departments of Psychiatry and Human Behavior

Received 14 March 2003 ,Revised 21 May 2003 ,Accepted 17 June 2004.

References 

  1. Goldenberg RL, Jobe AH. Prospects for research in reproductive health and birth outcomes. JAMA. 2001;285:633–639
  2. Challis JR, Sloboda D, Matthews SG, Holloway A, Alfaidy N, Patel FA, et al. The fetal placental hypothalarnic-pituitary-adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol. 2001;185:135–144
  3. Hillhouse EW, Grammatopoulos DK. Role of stress peptides during human pregnancy and labour. Reproduction. 2002;124:323–329
  4. Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regul Pept. 2002;108:159–164
  5. Chrousos GP, Gold PW. The concepts and stress and stress systems disorders. JAMA. 1992;267:1244–1252
  6. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. Elevated levels of. umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrin Metabol. 1993;77:1174–1179
  7. Erickson K, Thorsen P, Chrousos G, Grigoriadis DE, Khongsaly O, McGregor J, et al. Preterm birth: associated neuroendocrine, medical, and behavioral risk factors. J Clin Endocrinol Metab. 2001;86:2544–2552
  8. Hoawad AH, Goldenberg RL, Mercer B, Meis PJ, Iams JD, Das A, et al. The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol. 2002;186:990–996
  9. Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol. 1999;180(1 Pt 3):S257–S263
  10. Holzman C, Jetton J, Siler-Khodr T, Fisher R, Rip T. Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstet Gynecol. 2001;97(5 Pt l):657–663
  11. Inder WJ, Prickett TC, Ellis MJ, Hull L, Reid R, Benny PS, et al. The utility of plasma CRH as a predictor of preterm delivery. J Clin Endocrinol Metab. 2001;86:5706–5710
  12. Korebrits C, Ramirez MM, Watson L, Brinkman E, Bocking AD, Challis JR. Maternal CRH is increased with impending preterm birth. J Clin Endocrinol Metab. 1998;83:1585–1591
  13. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med. 1995;1:460–463
  14. Ruiz RJ, Fullerton J, Brown CE, Dudley DJ. Predicting risk of preterm birth: the roles of stress, clinical risk factors, and corticotropin-releasing hormone. Biol Res Nurs. 2002;4:54–64
  15. Wadhwa PD, Porto M, Chicz-DeMet A, Sandman CA. Maternal CRH levels in early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol. 1998;179:1079–1085
  16. Giles WB, McLean M, Davies JJ, Smith R. Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone. Obstet Gynecol. 1996;87:107–111
  17. Hobel CJ, Arora CP, Korst LM. Corticotrophin-releasing hormone and CRH-binding protein: differences between patients at risk for preterm birth and hypertension. Ann N Y Acad Sci. 1999;897:54–65
  18. Warren WB, Gurewitsch ED, Goland RS. Corticotropin-releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertension. Am J Obstet Gynecol. 1995;172:661–666
  19. Mercer BM, Goldenberg RL, Das A, Moawad AH, Iams JD, Meis PJ, et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol. 1996;174:1885–1893
  20. O'Brien GD, Queenan JT, Campbell S. Assessment of gestational age in the second trimester by real-time ultrasound measurement of the femur length. Am J Obstet Gynecol. 1981;139:540
  21. Smith R, Mesiano S, Chan EC, Brown S, Jaffe RB. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion in fetal adrenal cortical cells. J Clin Endocrinol Metab. 1998;83:2916–2920
  22. Chakravorty A, Mesiano S, Jaffe RB. Corticotropin-releasing hormone stimulates P450 17 alpha-hydroxylase/17, 20-lyase in human fetal adrenal cells via protein kinase C. J Clin Endocrinol Metab. 1999;84:3732–3738
  23. Aggelidou E, Hillhouse EW, Grammatopoulos DK. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc Natl Acad Sci U S A. 2002;99:3300–3305
  24. Clifton VL, Read MA, Leitch IM, Boura AL, Robinson PJ, Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab. 1994;79:666–669
  25. Donoghue JF, Leitch IM, Boura AL, Walters WA, Giles WB, Smith R, et al. Fetal placental vascular responses to corticotropin-releasing hormone in vitro: effects of variation in oxygen tension. Placenta. 2000;21:711–717
  26. King BR, Smith R, Nicholson RC. The regulation of human corticotrophin-releasing hormone gene expression in the placenta. Peptides. 2001;22:1941–1947
  27. McCarton CM, Wallace IF, Divon M, Vaughan HG. Cognitive and neurologic development of the premature, small for gestational age infant through age 6: comparison by birth weight and gestational age. Pediatrics. 1996;98(6 Pt 1):1167–1178
  28. McGrath S, McLean M, Smith D, Bisits A, Giles W, Smith R. Maternal plasma corticotropin-releasing hormone trajectories vary depending on the cause of preterm delivery. Am J Obstet Gynecol. 2002;186:257–260
  29. Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol. 1989;160:247–251
  30. Wadhwa PD, Sandman CA, Chicz-DeMet A, Porto M. Placental CRH modulates maternal pituitary adrenal function in human pregnancy. Ann N Y Acad Sci. 1997;814:276–281
  31. Chan EQ, Smith R, Lewin T, Brinsmead MW, Zhang HP, Cubis J, et al. Plasma corticotropin-releasing hormone, beta-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol (Copenh). 1993;128:339–344
  32. Florio P, Severi FM, Ciarmela P, Fiore G, Calonaci G, Merola A, et al. Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family. Endocrine. 2002;19:91–102
  33. Wadhwa PD, Glynn L, Hobel CJ, Garite TJ, Porto M, Chicz-De Met A, et al. Behavioral perinatology: biobehavioral processes in human fetal development. Regul Pept. 2002;108:149–157
  34. Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, Porto M, Sandman CA. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med. 1996;58:432–446
  35. Petraglia F, Hatch MC, Lapinski R, Stomati M, Reis FM, Cobellis L, et al. Lack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks' gestation. J Soc Gynecol Investig. 2001;8:83–88

 Supported in part by US PHS (NIH) grants HD-28413, HD-33506, and HD-041696.

PII: S0002-9378(04)00685-4

doi: 10.1016/j.ajog.2004.06.070

American Journal of Obstetrics & Gynecology
Volume 191, Issue 4 , Pages 1063-1069 , October 2004

Article Tools

* Image Usage & Resolution